Im­pel lever­ages big-time mi­graine cam­paigns from com­peti­tors Ab­b­Vie, Bio­haven for its in­tranasal Trud­he­sa launch

Small phar­ma play­ers can’t match the big-time ad­ver­tis­ing spend­ing of Big Phar­ma. But they can lever­age it — and that’s ex­act­ly what Im­pel Phar­ma­ceu­ti­cals is do­ing in the crowd­ed mi­graine cat­e­go­ry.

Ab­b­Vie’s Ubrelvy and Bio­haven’s Nurtec ODT are two of the lead­ing brands spend­ing mil­lions on TV ads and celebri­ty spokes­peo­ple for tra­di­tion­al, dig­i­tal and so­cial cam­paigns. How­ev­er, their ads don’t on­ly dri­ve in­di­vid­ual brand aware­ness, they’re al­so help­ing to dri­ve pa­tients in gen­er­al to doc­tors’ of­fices, Im­pel chair­man and CEO Adri­an Adams said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER